New England Capital Financial Advisors LLC Abbott Laboratories Transaction History
New England Capital Financial Advisors LLC
- $179 Billion
- Q2 2024
A detailed history of New England Capital Financial Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, New England Capital Financial Advisors LLC holds 523 shares of ABT stock, worth $58,701. This represents 0.03% of its overall portfolio holdings.
Number of Shares
523
Previous 523
-0.0%
Holding current value
$58,701
Previous $59.4 Million
8.55%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,138Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.35 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.06 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.42 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $197B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...